To achieve a consistently high level of income, with capital growth.
Name | % Net Assets |
---|---|
Vodafone Group | 5.1% |
GLAXOSMITHKLINE | 5.0% |
Astrazeneca | 5.0% |
Unilever | 4.9% |
British American Tobacco | 4.6% |
BP | 4.2% |
Royal Dutch Shell B | 4.1% |
Centrica | 3.9% |
BT group | 3.7% |
BG Group | 3.4% |
Key | % Net Assets |
---|---|
Vodafone Group | 5.1% |
GLAXOSMITHKLINE | 5.0% |
Astrazeneca | 5.0% |
Unilever | 4.9% |
Other | 80% |
Date | 22-Sep-2010 |
---|---|
NAV | 154.10p |
Currency | GBP |
Change | -2.05p |
% | -1.31% |
YTD change | 154.10p |
YTD % | n/a |
Fund Inception | 28/02/2002 |
---|---|
Fund Manager | Daniel Roberts |
TER | 0.76 (15-Apr-2010) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | £100 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research